Compugen to Present at Jefferies 2012 Global Healthcare Conference
November 14 2012 - 7:00AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN) today announced that its President
and Chief Executive Officer, Dr. Anat Cohen-Dayag, will be
presenting at the Jefferies 2012 Global Healthcare Conference in
London on Thursday, November 15. The title of her presentation is
“Predictive Discovery of Novel, Targeted Medicines.”
The presentation will be available after the conference on
Compugen's website, at http://www.cgen.com
About CompugenCompugen is a leading therapeutic product
discovery company focused on therapeutic proteins and monoclonal
antibodies to address important unmet needs in the fields of
immunology and oncology. Unlike traditional high throughput trial
and error experimental based discovery, Compugen utilizes a broad
and continuously growing integrated infrastructure of proprietary
scientific understandings and predictive platforms, algorithms,
machine learning systems and other computational biology
capabilities for the in silico (by computer) prediction and
selection of product candidates, which are then advanced in its
Pipeline Program to the pre-IND stage. The Company's business model
primarily involves collaborations covering the further development
and commercialization of product candidates from its Pipeline
Program and various forms of research and discovery agreements, in
both cases providing Compugen with potential milestone payments and
royalties on product sales or other forms of revenue sharing. In
2012, Compugen established operations in California for the
development of oncology and immunology monoclonal antibody
therapeutic candidates against Compugen-discovered drug targets. In
2002, Compugen established an affiliate, Evogene Ltd.,
(www.evogene.com) (TASE: EVGN.TA), to utilize certain of the
Company's in silico predictive discovery capabilities in
agricultural biotechnology. For additional information, please
visit Compugen's corporate website at www.cgen.com.
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jul 2023 to Jul 2024
